Larvol Delta - UKMPSIII-An-Efficacy-and-Safety-Study-of-GNR068-Ustekinumab-Biosimilar-and-Stelara174-in-the-Treatment-of-Patients-With-Moderate-to-Severe-Plaque-Psoriasis

Styleikin (ustekinumab biosimilar) - Generium

Stelara (ustekinumab) - J&J

http://clinicaltrials.gov/ct2/show/NCT06488664

Sep 21, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next